Deadline Alert: Beta Bionics, Inc. (BBNX) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

A class action lawsuit has been filed against Beta Bionics, Inc. (NASDAQ: BBNX) alleging securities fraud for failing to disclose material information about FDA safety violations and product issues. The company allegedly omitted over 18,000 complaints including life-threatening hypoglycemic events from FDA reports and misrepresented the severity of FDA observations. The lawsuit covers investors who purchased shares between July 30, 2025 and February 24, 2026, with a November 3, 2026 deadline to file as lead plaintiff.